• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intensive glycemic control: implications of the accord, advance, and VADT trials for family physicians.

作者信息

Dhar Gauranga Chandra

机构信息

Bangladesh Institute of Family Medicine and Research at the University of Science and Technology of Chittagong in Dhaka, Bangladesh.

出版信息

Can Fam Physician. 2009 Aug;55(8):803-4.

PMID:19675265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2726096/
Abstract
摘要

相似文献

1
Intensive glycemic control: implications of the accord, advance, and VADT trials for family physicians.强化血糖控制：ACCORD、ADVANCE及VADT试验对家庭医生的启示
Can Fam Physician. 2009 Aug;55(8):803-4.
2
Intensive glucose control and cardiovascular disease in type 2 diabetes--should we change the recommended target for glycated hemoglobin? Commentary to ACCORD and ADVANCE trials.2型糖尿病强化血糖控制与心血管疾病——我们是否应该改变糖化血红蛋白的推荐目标？对ACCORD和ADVANCE试验的评论
Pol Arch Med Wewn. 2008 Nov;118(11):619-21.
3
Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.2型糖尿病中的心血管疾病与强化血糖控制：推动实践走向基于证据的策略
Vasc Health Risk Manag. 2009;5:859-71. doi: 10.2147/vhrm.s4808. Epub 2009 Nov 2.
4
Diabetes. Insights from the extended follow-up of the ACCORD trial.糖尿病。ACCORD 试验延长随访的见解。
Nat Rev Cardiol. 2011 Jun;8(6):308-10. doi: 10.1038/nrcardio.2011.65. Epub 2011 Apr 19.
5
Cardiac risk factors and hypoglycemia in an elderly patient: how good is good enough?老年患者的心脏危险因素与低血糖：多好才算足够好？
Consult Pharm. 2010 Jun;25 Suppl B:19-27.
6
Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes.回到血糖控制：对2型糖尿病心血管结局试验结果的另一种审视。
Nutr Metab Cardiovasc Dis. 2017 Apr;27(4):375-377. doi: 10.1016/j.numecd.2017.01.003. Epub 2017 Jan 16.
7
[Hypoglycemia and cardiovascular risk].[低血糖与心血管风险]
G Ital Cardiol (Rome). 2014 Dec;15(12 Suppl 2):4S-12S. doi: 10.1714/1762.19110.
8
ACCORD and ADVANCE: a tale of two studies on the merits of glycaemic control in type 2 diabetic patients.控制糖尿病心血管风险行动（ACCORD）和糖尿病与血管疾病行动（ADVANCE）：两项关于2型糖尿病患者血糖控制益处的研究故事
Nephrol Dial Transplant. 2008 Jun;23(6):1796-8. doi: 10.1093/ndt/gfn200. Epub 2008 Apr 10.
9
Intensified glucose control in type 2 diabetes--whose agenda?2型糖尿病强化血糖控制——谁的议程？
Lancet. 2011 Apr 9;377(9773):1220-2. doi: 10.1016/S0140-6736(10)61112-9. Epub 2010 Nov 18.
10
Diabetes specialists keep ACCORD data in perspective.糖尿病专家正确看待糖尿病控制与并发症试验（ACCORD）的数据。
Am J Health Syst Pharm. 2008 Mar 15;65(6):488, 490. doi: 10.2146/news080021.

引用本文的文献

1
Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11).2型糖尿病患者的肾小球滤过率及心血管事件、死亡率和严重低血糖的相关风险：二次分析（DEVOTE 11）
Diabetes Ther. 2020 Jan;11(1):53-70. doi: 10.1007/s13300-019-00715-x. Epub 2019 Oct 30.
2
Continuous Glucose Monitoring Systems: A Review.连续血糖监测系统：综述。
Diagnostics (Basel). 2013 Oct 29;3(4):385-412. doi: 10.3390/diagnostics3040385.
3
Safety, tolerability, and efficacy of insulin aspart in people with type 2 diabetes, as biphasic insulin aspart or with Basal insulin: findings from the multinational, non-interventional a1chieve study.在 2 型糖尿病患者中，使用门冬胰岛素或与基础胰岛素联用的门冬胰岛素双相作为治疗方案的安全性、耐受性和疗效：来自多国、非干预性 a1chieve 研究的结果。
Diabetes Ther. 2014 Jun;5(1):113-26. doi: 10.1007/s13300-014-0052-4. Epub 2014 Jan 30.
4
Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling.糖尿病性卒中的血管保护：基质金属蛋白酶依赖性血管重塑的作用。
J Cereb Blood Flow Metab. 2010 Dec;30(12):1928-38. doi: 10.1038/jcbfm.2010.120. Epub 2010 Jul 28.

本文引用的文献

1
Glucose control and vascular complications in veterans with type 2 diabetes.2型糖尿病退伍军人的血糖控制与血管并发症
N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17.
2
Effects of intensive glucose lowering in type 2 diabetes.强化降糖对2型糖尿病的影响。
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
3
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.2型糖尿病患者强化血糖控制与血管转归
N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.
4
Redefining quality--implications of recent clinical trials.重新定义质量——近期临床试验的影响
N Engl J Med. 2008 Jun 12;358(24):2537-9. doi: 10.1056/NEJMp0803740. Epub 2008 Jun 6.
5
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.磺脲类或胰岛素强化血糖控制与传统治疗及2型糖尿病患者并发症风险的比较（英国前瞻性糖尿病研究[UKPDS 33]）。英国前瞻性糖尿病研究（UKPDS）小组
Lancet. 1998 Sep 12;352(9131):837-53.
6
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.糖尿病强化治疗对胰岛素依赖型糖尿病长期并发症发生及进展的影响。
N Engl J Med. 1993 Sep 30;329(14):977-86. doi: 10.1056/NEJM199309303291401.